the Company agreed to pay an amount equal to 2% of Net Sales (as defined in the Athanor Agreement) for the Product (as defined in the Athanor Agreement) to the extent such Net Sales (collectively, th…
We are party to a license agreement with Pfizer under which we were granted rights to certain patents, know-how and technology that are important and necessary to our business, including for crebankitug.
Reciprocal relationship from PFE graph: Reciprocal relationship from ZURA graph: We are party to a license agreement with Pfizer under which we were granted rights to certain patents, know-how and te…
If the Company manufactures all of its commercial supplies of bulk drug product for WuXi Biologics Licensed Products with a manufacturer other than WuXi Biologics or its affiliates, the Company is re…
the Company and its subsidiaries, on the one hand, and Stone Peach or BAFFX17, on the other hand, including the extinguishment of any and all rights or claims Stone Peach or BAFFX17 may have under al…
the Company and its subsidiaries, on the one hand, and Stone Peach or BAFFX17, on the other hand, including the extinguishment of any and all rights or claims Stone Peach or BAFFX17 may have under al…
nst such party. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights and failure to obtain or maintain trade secret protection could ad…
Reciprocal relationship from SNYNF graph: Reciprocal relationship from ZURA graph: nst such party. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our pr…
nst such party. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights and failure to obtain or maintain trade secret protection could ad…
Reciprocal relationship from SNYNF graph: Reciprocal relationship from ZURA graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from ZURA graph: nst such party. Costly and time-c…
Zura Bio Limited Debt Obligations
Instrument
Description
Confidence
Evidence
ZURA-DEBT-13792
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2023-12-31.
ZURA-DEBT-13791
Warrants outstanding: 0.001
90%
xbrl warrant detail from xbrl 2025-09-30.
Zura Bio Limited Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Zura Bio Limited.
Zura Bio Limited Ownership
Holder
Name
Confidence
Evidence
ZURA-OWNER-SUVRETTA-CAPITAL-MANAGEMENT-LLC
SUVRETTA CAPITAL MANAGEMENT, LLC
90%
13F overlay lists SUVRETTA CAPITAL MANAGEMENT, LLC as top holder; 95 tracked holders.